Microvention, based in Tustin, CA, is a global neurovascular company specializing in cutting-edge products for aneurysm therapy, ischemic stroke, carotid artery disease, and neurovascular malformations. Their innovative portfolio is backed by numerous clinical studies and independent research, setting the standard for performance and versatility in neuroendovascular therapies.
With a focus on professional growth and innovation, Microvention offers a collaborative work environment where employees can contribute to the advancement of neuroendovascular therapy. Their FDA PMA approved devices, such as the intrasaccular flow disruptors for aneurysm embolization, demonstrate a commitment to excellence and patient care in the field of neurovascular medicine.
Generated from the website